Who owns Intercept Pharmaceuticals In Note 2.000 5/1 bnd?

Top Holders and Investors of Intercept Pharmaceuticals In Note 2.000 5/1 bnd Stock

Find out what company owns Intercept Pharmaceuticals In Note 2.000 5/1 bnd, who bought Intercept Pharmaceuticals In Note 2.000 5/1 bnd this quarter, and who sold shares of Intercept Pharmaceuticals In Note 2.000 5/1 bnd stock?

Fund or Company Name Number of Shares Valued At As Of
Franklin Resources 35.50M $31.95M Sep 2019
Linden Advisors 28.53M $25.96M Sep 2019
Wolverine Asset Management 19.00M $17.29M Sep 2019
Highbridge Capital Management 18.00M $16.38M Sep 2019
Citadel Advisors 16.00M $14.56M Sep 2019
Lazard Asset Management 16.00M $14.40M Sep 2019
CNH Partners 9.85M $8.87M Sep 2019
SSI Investment Management 6.01M $5.41M Sep 2019
Barclays 5.76M $5.19M Sep 2019
Css Llc/il 5.75M $5.23M Sep 2019
Fmr 5.21M $4.69M Sep 2019
Polar Securities 5.00M $4.55M Sep 2019
Rima Management 5.00M $4.55M Sep 2019
Calamos Advisors 5.00M $6.65M Dec 2019
Context Capital Management 4.99M $4.49M Sep 2019
Deutsche Bank Aktiengesellschaft 3.84M $3.45M Sep 2019
Magnetar Financial 3.75M $3.41M Sep 2019
Gabelli Funds 3.30M $3.00M Sep 2019
Bnp Paribas Arbitrage, Snc 2.08M $1.87M Sep 2019
Antara Capital 2.00M $1.80M Sep 2019
Wellington Management Company 1.95M $1.75M Sep 2019
Morgan Stanley 1.68M $1.54M Sep 2019
Susquehanna International 1000000 $900000 Sep 2019
Bank of New York Mellon 500000 $450000 Sep 2019
Bank of America Corporation 427000 $384300 Sep 2019
Goldman Sachs 352000 $316800 Sep 2019
Gabelli Securities 350000 $318500 Sep 2019
Teton Advisors 300000 $273000 Sep 2019
First Hawaiian Bank 119000 $157080 Dec 2019
SG Americas Securities 95000 $8.59M Sep 2019

Who sold Intercept Pharmaceuticals In Note 2.000 5/1 bnd?

Fund Name Date Sold Shares Held Valued At
Nomura Holdings June 30, 2019 10.00M $0
Allianz Asset Management AG June 30, 2019 8.63M $8.54M
Wells Fargo & Company June 30, 2019 39000 $39000